With support from a $2.5 million NIH grant, UB chemist David Heppner is trying to answer key questions about the time-consuming and costly drug discovery process.
The COMPASS trial provides more evidence that aspiration-based thrombectomy is a safe and effective alternative for patients with acute ischemic stroke.